SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-089298
Filing Date
2023-08-09
Accepted
2023-08-09 16:05:26
Documents
16
Period of Report
2023-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2323211d1_8k.htm   iXBRL 8-K 30105
2 EXHIBIT 99.1 tm2323211d1_ex99-1.htm EX-99.1 59458
7 GRAPHIC tm2323211d1_ex99-1img02.jpg GRAPHIC 8561
8 GRAPHIC tm2323211d1_ex99-1img01.jpg GRAPHIC 5953
  Complete submission text file 0001104659-23-089298.txt   337079

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cycc-20230809.xsd EX-101.SCH 3260
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cycc-20230809_def.xml EX-101.DEF 26928
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycc-20230809_lab.xml EX-101.LAB 36551
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycc-20230809_pre.xml EX-101.PRE 25552
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2323211d1_8k_htm.xml XML 4945
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 231155081
SIC: 2834 Pharmaceutical Preparations